|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 249/04 | (2006.01) |
| C07D 401/12 | (2006.01) | ||
| A61K 51/04 | (2006.01) |
| (11) | Number of the document | 3643707 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18820848.2 |
| Date of filing the European patent application | 2018-06-18 | |
| (97) | Date of publication of the European application | 2020-04-29 |
| (45) | Date of publication and mention of the grant of the patent | 2022-02-23 |
| (46) | Date of publication of the claims translation | 2022-05-25 |
| (86) | Number | PCT/KR2018/006869 |
| Date | 2018-06-18 |
| (87) | Number | WO 2018/236115 |
| Date | 2018-12-27 |
| (30) | Number | Date | Country code |
| 20170077570 | 2017-06-19 | KR |
| (72) |
CHI, Dae Yoon , KR
LEE, Byoung Se , KR
CHU, So Young , KR
KIM, Min Hwan , KR
JUNG, Woon Jung , KR
JEONG, Hyeon Jin , KR
LEE, Kyo Chul , KR
LEE, Yong Jin , KR
PARK, Ji Ae , KR
KIM, Mi Hyun , KR
YOO, Ran Ji , KR
LIM, Sang Moo , KR
|
| (73) |
Futurechem Co., Ltd. ,
2nd Floor
21 Yeonmujang 3-gil
Seongdong-gu, Seoul 04782,
KR
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | 18F žymėtas junginys, skirtas prostatos vėžio diagnostikai ir jo panaudojimas |
| 18F-LABELLED COMPOUND FOR PROSTATE CANCER DIAGNOSIS, AND USE THEREOF |
| Payment date | Validity (years) | Amount | |
| 2026-05-19 | 9 | 208.00 EUR |
| 2027-06-18 |